All-in-one pressure, flow control, and imaging for culturing and monitoring lymphatic microphysiologic system
Active Definitive Contract Awarded Last action
- Contract number
- 75N91024C00018
- Awardee
-
Lymphatech, Inc. UEI W7JWEZ412CR3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $4,100,000
Award facts
- Opportunity
-
- Research and development (R&D) that will contribute toward Advanced Research Projects Agency for Health (ARPA-H) mission needs and Small Business Innovation Research (SBIR) program objectives. Pre-Solicitation · 75N91024R00006 · Posted Jan 8, 2024
- Contract value 100% obligated
- $4,100,000.00 Current and potential, with all options
- Completion date 53% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30318, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $3,500,000 | |
| Transfer Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $600,000 |
About this award
The National Institutes of Health awarded a $4.1 million Firm Fixed Price contract to Lymphatech, Inc., a small business based in Atlanta, Georgia, on September 13, 2024. This Small Business Innovation Research Program Phase I award supports the development of an all-in-one pressure, flow control, and imaging system for culturing and monitoring lymphatic microphysiologic systems. The contract is designated as a Total Small Business set-aside, limiting competition to firms meeting small business criteria. The project is expected to conclude by September 12, 2028 and falls under the broader Advanced Research Projects Agency for Health initiative, which focuses on high-risk, high-reward biomedical research to advance NIH's mission.
The original pre-solicitation, posted in January 2024, sought proposals across multiple topic areas including lymphatic system modeling, with evaluation and selection completed by the National Cancer Institute. Lymphatech's award reflects the government's commitment to innovative biomedical device development through small business partnerships, specifically targeting research that advances understanding and monitoring capabilities for lymphatic physiology. This contract represents the NIH's investment in early-stage research and development that may lead to significant advances in tissue engineering and microphysiologic system technology.
Quick answers
Who was awarded contract 75N91024C00018?
75N91024C00018 was awarded to Lymphatech, Inc. by National Institutes of Health (Department of Health and Human Services) on September 13, 2024.
How much is contract 75N91024C00018 worth?
The government has obligated $4,100,000 on 75N91024C00018.
Was contract 75N91024C00018 competed?
The extent of competition for 75N91024C00018 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award